Tianxing Zhou

6PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 04, 2026
CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer.

|Mar 27, 2026
Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Tianxing Zhou, Jingrui Yan, Guohua Mao

|Feb 06, 2026
Senescence as the Next Frontier in Cancer Research: Navigating the Rising Tide of Geriatric Oncology.

Tianxing Zhou, Jingrui Yan, Yu Zhang

|Oct 29, 2025
Targeting Mast Cell Activation and MIF-Mediated Remodelling Enhances Chemotherapy Response in Pancreatic Cancer.

Libo Wang, Guangcong Shen, Guanpeng Xie

|Sep 22, 2025
Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Xiuchao Wang, Hongwei Wang, Meng Zhang

|Nov 14, 2024
DLL4-targeted CAR-T therapy sensitizes neoadjuvant chemotherapy via eliminating cancer stem cells and reshaping immune microenvironment in HER2+ breast cancer.

Jingrui Yan, Yongjie Xie, Ziyun Liu

Pageof 1

Frequent Collaborators

4 joint publications

Jihui Hao

3 joint publications

Shangheng Shi

2 joint publications

Xiuchao Wang

2 joint publications

Hongwei Wang